Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rajeev Krishnaney-Davison"'
Publikováno v:
Neurology International, Vol 3, Iss 2, Pp e10-e10 (2011)
Stroke is a leading cause of death and disability, leading to the development of various stroke models to test new treatments, most commonly in the rat. Human stroke trials focus on disability, related primarily to neurological deficits. To better mo
Externí odkaz:
https://doaj.org/article/f7c1edb0d90b43c5aa03ef438eeaf2c4
Publikováno v:
Problem Based Learning Discussions in Neuroanesthesia and Neurocritical Care ISBN: 9789811504570
The patient is a 7-month-old male, 8.4 kg, coming to the operating room after he was diagnosed with scaphocephaly secondary to sagittal synostosis. His mother noticed his head looked “different” with a “prominent forehead” and took him to see
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0c8f753ae0be5aa5bcdb481f8dfa7be
https://doi.org/10.1007/978-981-15-0458-7_7
https://doi.org/10.1007/978-981-15-0458-7_7
Publikováno v:
Anesthesia and analgesia. 130(4)
Background Patients with acute lung injury who received lower tidal volume (VT) ventilation had significantly fewer days with acute kidney injury (AKI) when compared to those receiving higher VTs. There is a paucity of studies on the relationship bet
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 22:304-308
Background Although administration of various stem cells has shown promise in stroke models, neural stem cells (NSCs) derived from human induced pluripotent stem cells (iPSCs) have advantages over other cell types. We studied whether these cells coul
Publikováno v:
Journal of stem cell researchtherapy.
Background: Neural cell transplantation is a promising therapy for stroke, but rejection of human cells in animal models is an obstacle to furthering this research. Many antirejection strategies have been reported, but few comparison data are availab
Publikováno v:
Stroke. 43
Background Transplantation of neural cells is a promising stroke recovery therapy requiring animal model research, but rejection of human xenografts is an obstacle. While a variety of immunosupression strategies have been reported, few comparison dat
Publikováno v:
Neurology International, Vol 3, Iss 2, Pp e10-e10 (2011)
Neurology International
Volume 3
Issue 2
Neurology International
Volume 3
Issue 2
Stroke is a leading cause of death and disability, leading to the development of various stroke models to test new treatments, most commonly in the rat. Human stroke trials focus on disability, related primarily to neurological deficits. To better mo